Related Experiment Video
Updated: Aug 9, 2026
07:02
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
Classic Kaposi's sarcoma: low-dose interferon alfa treatment
1Department of Dermatology, Sourasky Medical Center, Tel Aviv University, Sackler School of Medicine, Israel. Tur@eng.tau.ac.il
Dermatology (Basel, Switzerland)
|August 7, 1998
Summary
Low-dose interferon alfa shows promise for classic Kaposi's sarcoma, with significant lesion reduction and long remissions. Unlike AIDS-related cases, patients with classic Kaposi's sarcoma responded well to retreatment.
Area of Science:
- Oncology
- Dermatology
- Cancer Research
Background:
- Classic Kaposi's sarcoma (KS) is a rare cancer lacking a definitive cure.
- Case reports suggest potential benefits of low-dose interferon (IFN) alfa.
- This study evaluates subcutaneous low-dose IFN alfa in 11 patients with extensive classic KS.
Purpose of the Study:
- To assess the efficacy and safety of low-dose subcutaneous interferon alfa treatment for classic Kaposi's sarcoma.
- To compare treatment outcomes with those observed in AIDS-related Kaposi's sarcoma.
Main Methods:
- 11 patients (56-96 years old; 10 male, 1 female) with classic KS received subcutaneous IFN alfa.
- Initial dosage: 3 million units 5 times/week, adjusted based on response and side effects (2-6 million units, 3-6 times/week).
- Treatment duration was 6 months, with adjustments for patient outcomes and recurrences.
Main Results:
- 9 out of 11 patients showed initial response within 3-13 weeks, characterized by reduced lesion size and color.
- Maximum response observed at 4-6 months, with remissions lasting 4-72 months.
- Recurrences were effectively retreated, achieving additional remissions in 5-8 weeks; side effects like fever and fatigue were manageable with dose reduction.
Conclusions:
- Low-dose IFN alfa is effective in treating classic Kaposi's sarcoma, inducing partial resolution and long-term remission.
- Patients with classic KS did not develop refractoriness to IFN alfa, unlike those with AIDS-related KS.
- Recurrences in classic KS were responsive to retreatment, and continuous therapy was not always necessary.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...